FIA
AMED

FNY Investment Advisers’s Amedisys AMED Stock Holding History

FNY Investment Advisers’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-71
Closed -$6K – 713
2024
Q4 		$6K Buy
+71
New +$6.52K ﹤0.01% 522

Other funds holding AMED

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MCI
MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

FNY Investment Advisers's AMED Position: Q3 2025 in Review

FNY Investment Advisers sold out of Amedisys (AMED) in Q3 2025, closing a stake of 6,750 shares — an estimated $664K sold.

FNY Investment Advisers first reported a position in AMED in Q4 2018 and held it in 5 quarters. The position peaked at $1.1M in Q2 2024. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • FNY Investment Advisers reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • FNY Investment Advisers sold 6,750 Amedisys shares in Q3 2025, an estimated $664K.
  • FNY Investment Advisers first reported a position in Amedisys in Q4 2018 and held it in 5 quarters.
  • FNY Investment Advisers's Amedisys position peaked at $1.1M in Q2 2024.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on FNY Investment Advisers's 13F filing for Q3 2025, filed 15 Dec 2025.